back to top
- Reducing the Likelihood of Harm Associated With Use of Anticoagulant TherapyOctober 04, 2019 | November-December 2019, Volume 16, Issue 6
Dr. May and Dr. Moll describe the Joint Commission's guidelines and resources for reducing the likelihood of harm associated with use of anticoagulant therapy.
- Is the Future of the Benign Hematology Consult Electronic?August 15, 2019 | September-October 2019, Volume 16, Issue 5
Drs. May and Moll discuss an exciting, promising new approach that maximizes access to nonmalignant hematology expertise: a virtual nonmalignant hematology consultation service, commonly referred to as an electronic consultation or e-consult.
- Thromboprophylaxis in Ambulatory Cancer Patients: Results of the AVERT TrialFebruary 25, 2019 | March-April 2019, Volume 16, Issue 2
Drs. May and Moll discuss the AVERT Trial, which provides a novel approach to thromboprophylaxis in ambulatory patients with cancer.
- The Year's Best in Thrombosis: ESUS – Management of Unexplained Arterial ThromboembolismDecember 21, 2018 | January-February 2019, Volume 16, Issue 1
Dr. Jori May and Dr. Moll shed light on 2018 advances on the topic of unexplained arterial thromboembolism.
Dr. May is a fellow in the Division of Hematology/Oncology at the University of Alabama at Birmingham.